{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,18]],"date-time":"2026-11-18T13:57:12Z","timestamp":1795010232539,"version":"4.9.1"},"reference-count":52,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2023,11,30]],"date-time":"2023-11-30T00:00:00Z","timestamp":1701302400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2023,11,30]],"date-time":"2023-11-30T00:00:00Z","timestamp":1701302400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["AAPS PharmSciTech"],"DOI":"10.1208\/s12249-023-02705-6","type":"journal-article","created":{"date-parts":[[2023,11,30]],"date-time":"2023-11-30T22:12:51Z","timestamp":1701382371000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":12,"title":["The Modified Exenatide Microspheres: PLGA-PEG-PLGA Gel and Zinc-Exenatide Complex Synergistically Reduce Burst Release and Shorten Platform Stage"],"prefix":"10.1208","volume":"24","author":[{"given":"Wenjing","family":"Jiang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiangjun","family":"Gao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qiuli","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yang","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dan","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoyan","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8319-5151","authenticated-orcid":false,"given":"Xinggang","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,11,30]]},"reference":[{"issue":"11","key":"2705_CR1","doi-asserted-by":"publisher","first-page":"1271","DOI":"10.1097\/01.smj.0000240730.86237.b6","volume":"99","author":"N Mikhail","year":"2006","unstructured":"Mikhail N. Exenatide: a novel approach for treatment of type 2 diabetes. Southern Med J. 2006;99(11):1271\u20139. https:\/\/doi.org\/10.1097\/01.smj.0000240730.86237.b6.","journal-title":"Southern Med J."},{"issue":"15","key":"2705_CR2","doi-asserted-by":"publisher","first-page":"2593","DOI":"10.1517\/14656566.8.15.2593","volume":"8","author":"Barnett A Exenatide","year":"2007","unstructured":"Exenatide Barnett A. Exp Opinion Pharmacotherap. 2007;8(15):2593\u2013608. https:\/\/doi.org\/10.1517\/14656566.8.15.2593.","journal-title":"Exp Opinion Pharmacotherap."},{"issue":"10","key":"2705_CR3","doi-asserted-by":"publisher","first-page":"1777","DOI":"10.1345\/aph.1H060","volume":"40","author":"BK Yoo","year":"2006","unstructured":"Yoo BK, Triller DM, Yoo DJ. Exenatide: a new option for the treatment of type 2 diabetes. Annals Pharmacotherap. 2006;40(10):1777\u201384. https:\/\/doi.org\/10.1345\/aph.1H060.","journal-title":"Annals Pharmacotherap."},{"issue":"14","key":"2705_CR4","doi-asserted-by":"publisher","first-page":"4121","DOI":"10.1016\/j.biomaterials.2010.01.091","volume":"31","author":"JH Kong","year":"2010","unstructured":"Kong JH, Oh EJ, Chae SY, Lee KC, Hahn SK. Long acting hyaluronate\u2013exendin 4 conjugate for the treatment of type 2 diabetes. Biomater. 2010;31(14):4121\u20138. https:\/\/doi.org\/10.1016\/j.biomaterials.2010.01.091.","journal-title":"Biomater."},{"key":"2705_CR5","doi-asserted-by":"publisher","first-page":"172","DOI":"10.1016\/j.peptides.2013.06.005","volume":"46","author":"J Xuan","year":"2013","unstructured":"Xuan J, Lin Y, Huang J, Yuan F, Li X, Lu Y, et al. Exenatide-loaded PLGA microspheres with improved glycemic control: in vitro bioactivity and in vivo pharmacokinetic profiles after subcutaneous administration to SD rats. Peptides. 2013;46:172\u20139. https:\/\/doi.org\/10.1016\/j.peptides.2013.06.005.","journal-title":"Peptides."},{"issue":"3","key":"2705_CR6","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1016\/j.ajps.2019.01.002","volume":"15","author":"N Dong","year":"2020","unstructured":"Dong N, Zhu C, Jiang J, Huang D, Li X, Quan G, et al. Development of composite PLGA microspheres containing exenatide-encapsulated lecithin nanoparticles for sustained drug release. Asian J Pharmaceut Sci. 2020;15(3):347\u201355. https:\/\/doi.org\/10.1016\/j.ajps.2019.01.002.","journal-title":"Asian J Pharmaceut Sci."},{"issue":"11","key":"2705_CR7","doi-asserted-by":"publisher","first-page":"2834","DOI":"10.1016\/j.biomaterials.2013.01.013","volume":"34","author":"K Li","year":"2013","unstructured":"Li K, Yu L, Liu X, Chen C, Chen Q, Ding J. A long-acting formulation of a polypeptide drug exenatide in treatment of diabetes using an injectable block copolymer hydrogel. Biomaterials. 2013;34(11):2834\u201342. https:\/\/doi.org\/10.1016\/j.biomaterials.2013.01.013.","journal-title":"Biomaterials."},{"key":"2705_CR8","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1016\/j.actbio.2021.04.009","volume":"128","author":"J Shi","year":"2021","unstructured":"Shi J, Yu L, Ding J. PEG-based thermosensitive and biodegradable hydrogels. Acta Biomater. 2021;128:42\u201359. https:\/\/doi.org\/10.1016\/j.actbio.2021.04.009.","journal-title":"Acta Biomater."},{"issue":"2","key":"2705_CR9","doi-asserted-by":"publisher","first-page":"333","DOI":"10.2337\/dc17-1306","volume":"41","author":"J Rosenstock","year":"2018","unstructured":"Rosenstock J, Buse JB, Azeem R, Prabhakar P, Kjems L, Huang H, et al. Efficacy and safety of ITCA 650, a novel drug-device GLP-1 receptor agonist, in type 2 diabetes uncontrolled with oral antidiabetes drugs: the FREEDOM-1 Trial. Diabetes Care. 2018;41(2):333\u201340. https:\/\/doi.org\/10.2337\/dc17-1306.","journal-title":"Diabetes Care."},{"issue":"5","key":"2705_CR10","doi-asserted-by":"publisher","first-page":"485","DOI":"10.1016\/0956-5663(95)96894-5","volume":"10","author":"E Wilkins","year":"1995","unstructured":"Wilkins E, Atanasov P, Muggenburg BA. Integrated implantable device for long-term glucose monitoring. Biosens Bioelectron. 1995;10(5):485\u201394. https:\/\/doi.org\/10.1016\/0956-5663(95)96894-5.","journal-title":"Biosens Bioelectron."},{"issue":"2","key":"2705_CR11","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1111\/j.1476-5381.2011.01227.x","volume":"163","author":"N Gong","year":"2011","unstructured":"Gong N, Ma AN, Zhang LJ, Luo XS, Zhang YH, Xu M, et al. Site-specific PEGylation of exenatide analogues markedly improved their glucoregulatory activity. British J Pharmacol. 2011;163(2):399\u2013412. https:\/\/doi.org\/10.1111\/j.1476-5381.2011.01227.x.","journal-title":"British J Pharmacol."},{"issue":"16","key":"2705_CR12","doi-asserted-by":"publisher","first-page":"1829","DOI":"10.4155\/fmc.14.125","volume":"6","author":"C Ginn","year":"2014","unstructured":"Ginn C, Khalili H, Lever R, Brocchini S. PEGylation and its impact on the design of new protein-based medicines. Future Med Chem. 2014;6(16):1829\u201346. https:\/\/doi.org\/10.4155\/fmc.14.125.","journal-title":"Future Med Chem."},{"key":"2705_CR13","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijpharm.2023.122863","volume":"636","author":"H Liu","year":"2023","unstructured":"Liu H, Wang B, Xing M, Meng F, Zhang S, Yang G, et al. Thermal stability of exenatide encapsulated in stratified dissolving microneedles during storage. Int J Pharm. 2023;636: 122863. https:\/\/doi.org\/10.1016\/j.ijpharm.2023.122863.","journal-title":"Int J Pharm."},{"key":"2705_CR14","doi-asserted-by":"publisher","unstructured":"Waghule T, Singhvi G, Dubey SK, Pandey MM, Gupta G, Singh M, et al. (2019) Microneedles: a smart approach and increasing potential for transdermal drug delivery system. Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie. 109:1249-58. https:\/\/doi.org\/10.1016\/j.biopha.2018.10.078.","DOI":"10.1016\/j.biopha.2018.10.078"},{"key":"2705_CR15","doi-asserted-by":"publisher","first-page":"114857","DOI":"10.1016\/j.addr.2023.114857","volume":"198","author":"B Wan","year":"2023","unstructured":"Wan B, Bao Q, Burgess D. Long-acting PLGA microspheres: advances in excipient and product analysis toward improved product understanding. Adv Drug Deliv Rev. 2023;198:114857. https:\/\/doi.org\/10.1016\/j.addr.2023.114857.","journal-title":"Adv Drug Deliv Rev."},{"issue":"1","key":"2705_CR16","doi-asserted-by":"publisher","first-page":"1397","DOI":"10.1080\/10717544.2021.1938756","volume":"28","author":"Y Su","year":"2021","unstructured":"Su Y, Zhang B, Sun R, Liu W, Zhu Q, Zhang X, et al. PLGA-based biodegradable microspheres in drug delivery: recent advances in research and application. Drug Deliv. 2021;28(1):1397\u2013418. https:\/\/doi.org\/10.1080\/10717544.2021.1938756.","journal-title":"Drug Deliv."},{"issue":"12","key":"2705_CR17","doi-asserted-by":"publisher","first-page":"1679","DOI":"10.2165\/11209750-000000000-00000","volume":"72","author":"LJ Scott","year":"2012","unstructured":"Scott LJ. Exenatide extended-release: a review of its use in type 2 diabetes mellitus. Drugs. 2012;72(12):1679\u2013707. https:\/\/doi.org\/10.2165\/11209750-000000000-00000.","journal-title":"Drugs."},{"issue":"11","key":"2705_CR18","doi-asserted-by":"publisher","first-page":"1145","DOI":"10.1089\/dia.2011.0050","volume":"13","author":"MB DeYoung","year":"2011","unstructured":"DeYoung MB, MacConell L, Sarin V, Trautmann M, Herbert P. Encapsulation of exenatide in poly-(D, L-lactide-co-glycolide) microspheres produced an investigational long-acting once-weekly formulation for type 2 diabetes. Diabetes Technol Therapeut. 2011;13(11):1145\u201354. https:\/\/doi.org\/10.1089\/dia.2011.0050.","journal-title":"Diabetes Technol Therapeut."},{"issue":"11","key":"2705_CR19","doi-asserted-by":"publisher","first-page":"1474","DOI":"10.1248\/cpb.58.1474","volume":"58","author":"B Liu","year":"2010","unstructured":"Liu B, Dong Q, Wang M, Shi L, Wu Y, Yu X, et al. Preparation, characterization, and pharmacodynamics of exenatide-loaded poly(DL-lactic-co-glycolic acid) microspheres. Chem Pharmaceu Bull. 2010;58(11):1474\u20139. https:\/\/doi.org\/10.1248\/cpb.58.1474.","journal-title":"Chem Pharmaceu Bull."},{"key":"2705_CR20","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijpharm.2023.123213","volume":"643","author":"A Chandrashekar","year":"2023","unstructured":"Chandrashekar A, Beig A, Wang Y, Schwendeman SP. In vitro performance of composition-equivalent PLGA microspheres encapsulating exenatide acetate by solvent evaporation. Int J Pharm. 2023;643: 123213. https:\/\/doi.org\/10.1016\/j.ijpharm.2023.123213.","journal-title":"Int J Pharm."},{"issue":"8","key":"2705_CR21","doi-asserted-by":"publisher","first-page":"1582","DOI":"10.1002\/jps.10414","volume":"92","author":"K Fu","year":"2003","unstructured":"Fu K, Harrell R, Zinski K, Um C, Jaklenec A, Frazier J, et al. A potential approach for decreasing the burst effect of protein from PLGA microspheres. J Pharm Sci. 2003;92(8):1582\u201391. https:\/\/doi.org\/10.1002\/jps.10414.","journal-title":"J Pharm Sci."},{"issue":"3","key":"2705_CR22","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1016\/s0142-9612(00)00178-2","volume":"22","author":"YY Yang","year":"2001","unstructured":"Yang YY, Chung TS, Ng NP. Morphology, drug distribution, and in vitro release profiles of biodegradable polymeric microspheres containing protein fabricated by double-emulsion solvent extraction\/evaporation method. Biomaterials. 2001;22(3):231\u201341. https:\/\/doi.org\/10.1016\/s0142-9612(00)00178-2.","journal-title":"Biomaterials."},{"issue":"2","key":"2705_CR23","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1016\/s0168-3659(02)00493-5","volume":"89","author":"M Shi","year":"2003","unstructured":"Shi M, Yang YY, Chaw CS, Goh SH, Moochhala SM, Ng S, et al. Double walled POE\/PLGA microspheres: encapsulation of water-soluble and water-insoluble proteins and their release properties. J Control Release. 2003;89(2):167\u201377. https:\/\/doi.org\/10.1016\/s0168-3659(02)00493-5.","journal-title":"J Control Release."},{"issue":"2","key":"2705_CR24","doi-asserted-by":"publisher","first-page":"505","DOI":"10.1016\/j.jconrel.2012.01.043","volume":"161","author":"F Danhier","year":"2012","unstructured":"Danhier F, Ansorena E, Silva JM, Coco R, Le Breton A, Pr\u00e9at V. PLGA-based nanoparticles: an overview of biomedical applications. J Control Release. 2012;161(2):505\u201322. https:\/\/doi.org\/10.1016\/j.jconrel.2012.01.043.","journal-title":"J Control Release."},{"issue":"1\u20132","key":"2705_CR25","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1016\/j.ijpharm.2006.10.036","volume":"334","author":"S Mao","year":"2007","unstructured":"Mao S, Xu J, Cai C, Germershaus O, Schaper A, Kissel T. Effect of WOW process parameters on morphology and burst release of FITC-dextran loaded PLGA microspheres. Int J Pharm. 2007;334(1\u20132):137\u201348. https:\/\/doi.org\/10.1016\/j.ijpharm.2006.10.036.","journal-title":"Int J Pharm."},{"issue":"10","key":"2705_CR26","doi-asserted-by":"publisher","first-page":"4247","DOI":"10.1016\/j.actbio.2014.06.018","volume":"10","author":"F Qi","year":"2014","unstructured":"Qi F, Wu J, Yang T, Ma G, Su Z. Mechanistic studies for monodisperse exenatide-loaded PLGA microspheres prepared by different methods based on SPG membrane emulsification. Acta Biomater. 2014;10(10):4247\u201356. https:\/\/doi.org\/10.1016\/j.actbio.2014.06.018.","journal-title":"Acta Biomater."},{"key":"2705_CR27","doi-asserted-by":"publisher","unstructured":"Lin, Xia, Yang, Hua, Lili, Ziyi, et al. Effect of size on the in vitro\/in vivo drug release and degradation of exenatide-loaded PLGA microspheres. J Drug Deliv Sci Tec. 2018;45:346-56. https:\/\/doi.org\/10.1016\/j.jddst.2018.03.024.","DOI":"10.1016\/j.jddst.2018.03.024"},{"key":"2705_CR28","doi-asserted-by":"publisher","unstructured":"Ge Y, Hu Z, Chen J, Qin Y, Wu F, Jin T. Exenatide microspheres for monthly controlled-release aided by magnesium hydroxide. Pharmaceutics. 2021;13(6). https:\/\/doi.org\/10.3390\/pharmaceutics13060816.","DOI":"10.3390\/pharmaceutics13060816"},{"key":"2705_CR29","doi-asserted-by":"publisher","unstructured":"Park H, Ha DH, Ha ES, Kim JS, Kim MS, Hwang SJ. Effect of stabilizers on encapsulation efficiency and release behavior of exenatide-loaded PLGA microsphere prepared by the W\/O\/W solvent evaporation method. Pharmaceutics. 2019;11(12). https:\/\/doi.org\/10.3390\/pharmaceutics11120627.","DOI":"10.3390\/pharmaceutics11120627"},{"issue":"1","key":"2705_CR30","doi-asserted-by":"publisher","first-page":"1667","DOI":"10.1080\/10717544.2020.1850919","volume":"27","author":"J Zhai","year":"2020","unstructured":"Zhai J, Ou Z, Zhong L, Wang YE, Cao LP, Guan S. Exenatide-loaded inside-porous poly(lactic-co-glycolic acid) microspheres as a long-acting drug delivery system with improved release characteristics. Drug Deliv. 2020;27(1):1667\u201375. https:\/\/doi.org\/10.1080\/10717544.2020.1850919.","journal-title":"Drug Deliv."},{"issue":"1\u20133","key":"2705_CR31","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1016\/s0168-3659(01)00276-0","volume":"72","author":"GM Zentner","year":"2001","unstructured":"Zentner GM, Rathi R, Shih C, McRea JC, Seo MH, Oh H, et al. Biodegradable block copolymers for delivery of proteins and water-insoluble drugs. J Control Release. 2001;72(1\u20133):203\u201315. https:\/\/doi.org\/10.1016\/s0168-3659(01)00276-0.","journal-title":"J Control Release."},{"issue":"1\u20132","key":"2705_CR32","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1016\/j.ijpharm.2007.07.026","volume":"348","author":"L Yu","year":"2008","unstructured":"Yu L, Chang GT, Zhang H, Ding JD. Injectable block copolymer hydrogels for sustained release of a PEGylated drug. Int J Pharm. 2008;348(1\u20132):95\u2013106. https:\/\/doi.org\/10.1016\/j.ijpharm.2007.07.026.","journal-title":"Int J Pharm."},{"issue":"5","key":"2705_CR33","doi-asserted-by":"publisher","first-page":"827","DOI":"10.1023\/b:pham.0000026435.27086.94","volume":"21","author":"S Choi","year":"2004","unstructured":"Choi S, Baudys M, Kim SW. Control of blood glucose by novel GLP-1 delivery using biodegradable triblock copolymer of PLGA-PEG-PLGA in type 2 diabetic rats. Pharm Res. 2004;21(5):827\u201331. https:\/\/doi.org\/10.1023\/b:pham.0000026435.27086.94.","journal-title":"Pharm Res."},{"issue":"4","key":"2705_CR34","doi-asserted-by":"publisher","first-page":"2458","DOI":"10.1002\/app.27823","volume":"108","author":"J Li","year":"2008","unstructured":"Li J, Jiang GQ, Ding FX. Effects of polymer degradation on drug release from PLGA-mPEG microparticles: a dynamic study of microparticle morphological and physicochemical properties. J Appli Polymer Sci. 2008;108(4):2458\u201366. https:\/\/doi.org\/10.1002\/app.27823.","journal-title":"J Appli Polymer Sci."},{"issue":"1","key":"2705_CR35","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1007\/s13346-016-0326-7","volume":"7","author":"S Mustafa","year":"2017","unstructured":"Mustafa S, Devi VK, Pai RS. Effect of PEG and water-soluble chitosan coating on moxifloxacin-loaded PLGA long-circulating nanoparticles. Drug Delivery Trans Res. 2017;7(1):27\u201336. https:\/\/doi.org\/10.1007\/s13346-016-0326-7.","journal-title":"Drug Delivery Trans Res."},{"key":"2705_CR36","doi-asserted-by":"publisher","first-page":"360","DOI":"10.1016\/j.colsurfb.2016.08.032","volume":"147","author":"P Wang","year":"2016","unstructured":"Wang P, Wang Q, Ren T, Gong H, Gou J, Zhang Y, et al. Effects of Pluronic F127-PEG multi-gel-core on the release profile and pharmacodynamics of Exenatide loaded in PLGA microspheres. Colloids Surfaces B, Biointerfaces. 2016;147:360\u20137. https:\/\/doi.org\/10.1016\/j.colsurfb.2016.08.032.","journal-title":"Colloids Surfaces B, Biointerfaces."},{"issue":"1\u20132","key":"2705_CR37","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1016\/j.ijpharm.2017.05.069","volume":"528","author":"P Wang","year":"2017","unstructured":"Wang P, Zhuo X, Chu W, Tang X. Exenatide-loaded microsphere\/thermosensitive hydrogel long-acting delivery system with high drug bioactivity. Int J Pharm. 2017;528(1\u20132):62\u201375. https:\/\/doi.org\/10.1016\/j.ijpharm.2017.05.069.","journal-title":"Int J Pharm."},{"issue":"4","key":"2705_CR38","doi-asserted-by":"publisher","first-page":"334","DOI":"10.1080\/02652040802354707","volume":"26","author":"C Cai","year":"2009","unstructured":"Cai C, Mao S, Germershaus O, Schaper A, Rytting E, Chen D, et al. Influence of morphology and drug distribution on the release process of FITC-dextran-loaded microspheres prepared with different types of PLGA. J Microencapsul. 2009;26(4):334\u201345. https:\/\/doi.org\/10.1080\/02652040802354707.","journal-title":"J Microencapsul."},{"issue":"10","key":"2705_CR39","doi-asserted-by":"publisher","first-page":"931","DOI":"10.1080\/1061186x.2018.1455839","volume":"26","author":"L Zhang","year":"2018","unstructured":"Zhang L, Shi Y, Song Y, Duan D, Zhang X, Sun K, et al. Tf ligand-receptor-mediated exenatide-Zn(2+) complex oral-delivery system for penetration enhancement of exenatide. J Drug Target. 2018;26(10):931\u201340. https:\/\/doi.org\/10.1080\/1061186x.2018.1455839.","journal-title":"J Drug Target."},{"key":"2705_CR40","doi-asserted-by":"crossref","unstructured":"5 - Mathematical models of drug release. In: Bruschi ML, editor. Strategies to modify the drug release from pharmaceutical systems: Woodhead Publishing; 2015. p. 63-86.","DOI":"10.1016\/B978-0-08-100092-2.00005-9"},{"issue":"7","key":"2705_CR41","doi-asserted-by":"publisher","first-page":"2857","DOI":"10.1021\/acs.molpharmaceut.8b00344","volume":"15","author":"S Ruan","year":"2018","unstructured":"Ruan S, Gu Y, Liu B, Gao H, Hu X, Hao H, et al. Long-acting release microspheres containing novel GLP-1 analog as an antidiabetic system. Molecular Pharmaceut. 2018;15(7):2857\u201369. https:\/\/doi.org\/10.1021\/acs.molpharmaceut.8b00344.","journal-title":"Molecular Pharmaceut."},{"issue":"5\u20136","key":"2705_CR42","doi-asserted-by":"publisher","first-page":"659","DOI":"10.1007\/s00775-016-1375-6","volume":"21","author":"GP Lisi","year":"2016","unstructured":"Lisi GP, Hughes RP, Wilcox DE. Coordination contributions to protein stability in metal-substituted carbonic anhydrase. J Biolog Inorganic Chem: JBIC\u202f: a Publication Society Biological Inorganic Chem. 2016;21(5\u20136):659\u201367. https:\/\/doi.org\/10.1007\/s00775-016-1375-6.","journal-title":"J Biolog Inorganic Chem: JBIC : a Publication Society Biological Inorganic Chem."},{"key":"2705_CR43","doi-asserted-by":"publisher","unstructured":"Li X,\u00a0Wei Y, Lv P, Wu Y, Ogino K, Ma G. Preparation of ropivacaine loaded PLGA microspheres as controlled-release system with narrow size distribution and high loading efficiency.\u00a0Colloids Surf A: Physicochem Eng Asp.\u00a02019;562:237\u201346. https:\/\/doi.org\/10.1016\/j.colsurfa.2018.11.014.","DOI":"10.1016\/j.colsurfa.2018.11.014"},{"issue":"1","key":"2705_CR44","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1016\/j.jconrel.2004.01.011","volume":"96","author":"J Siepmann","year":"2004","unstructured":"Siepmann J, Faisant N, Akiki J, Richard J, Benoit JP. Effect of the size of biodegradable microparticles on drug release: experiment and theory. J Control Release. 2004;96(1):123\u201334. https:\/\/doi.org\/10.1016\/j.jconrel.2004.01.011.","journal-title":"J Control Release."},{"issue":"1","key":"2705_CR45","doi-asserted-by":"publisher","first-page":"360","DOI":"10.1016\/j.ijpharm.2017.12.006","volume":"536","author":"C Busatto","year":"2018","unstructured":"Busatto C, Pesoa J, Helbling I, Luna J, Estenoz D. Effect of particle size, polydispersity and polymer degradation on progesterone release from PLGA microparticles: experimental and mathematical modeling. Int J Pharm. 2018;536(1):360\u20139. https:\/\/doi.org\/10.1016\/j.ijpharm.2017.12.006.","journal-title":"Int J Pharm."},{"issue":"44","key":"2705_CR46","doi-asserted-by":"publisher","first-page":"37452","DOI":"10.1039\/c6ra02994a","volume":"6","author":"Y Wang","year":"2016","unstructured":"Wang Y, Sun T, Zhang Y, Chaurasiya B, Huang L, Liu X, et al. Exenatide loaded PLGA microspheres for long-acting antidiabetic therapy: preparation, characterization, pharmacokinetics and pharmacodynamics. Rsc Adv. 2016;6(44):37452\u201362. https:\/\/doi.org\/10.1039\/c6ra02994a.","journal-title":"Rsc Adv."},{"issue":"1\u20132","key":"2705_CR47","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1016\/j.ijpharm.2011.05.049","volume":"415","author":"S Fredenberg","year":"2011","unstructured":"Fredenberg S, Wahlgren M, Reslow M, Axelsson A. The mechanisms of drug release in poly(lactic-co-glycolic acid)-based drug delivery systems\u2013a review. Int J Pharm. 2011;415(1\u20132):34\u201352. https:\/\/doi.org\/10.1016\/j.ijpharm.2011.05.049.","journal-title":"Int J Pharm."},{"issue":"4","key":"2705_CR48","doi-asserted-by":"publisher","first-page":"2602","DOI":"10.1021\/acs.chemrev.5b00346","volume":"116","author":"N Kamaly","year":"2016","unstructured":"Kamaly N, Yameen B, Wu J, Farokhzad OC. Degradable controlled-release polymers and polymeric nanoparticles: mechanisms of controlling drug release. Chem Rev. 2016;116(4):2602\u201363. https:\/\/doi.org\/10.1021\/acs.chemrev.5b00346.","journal-title":"Chem Rev."},{"key":"2705_CR49","doi-asserted-by":"publisher","first-page":"240","DOI":"10.1016\/j.jconrel.2014.05.057","volume":"190","author":"SP Schwendeman","year":"2014","unstructured":"Schwendeman SP, Shah RB, Bailey BA, Schwendeman AS. Injectable controlled release depots for large molecules. J Control Release. 2014;190:240\u201353. https:\/\/doi.org\/10.1016\/j.jconrel.2014.05.057.","journal-title":"J Control Release."},{"issue":"11","key":"2705_CR50","doi-asserted-by":"publisher","first-page":"1079","DOI":"10.2174\/1389201021666200101104116","volume":"21","author":"S Wang","year":"2020","unstructured":"Wang S, Feng X, Liu P, Wei Y, Xiao B. Blending of PLGA-PEG-PLGA for improving the erosion and drug release profile of PCL microspheres. Current Pharmaceut Biotechnol. 2020;21(11):1079\u201387. https:\/\/doi.org\/10.2174\/1389201021666200101104116.","journal-title":"Current Pharmaceut Biotechnol."},{"issue":"1","key":"2705_CR51","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1016\/j.jconrel.2005.09.007","volume":"110","author":"G Duncan","year":"2005","unstructured":"Duncan G, Jess TJ, Mohamed F, Price NC, Kelly SM, van der Walle CF. The influence of protein solubilisation, conformation and size on the burst release from poly(lactide-co-glycolide) microspheres. J Control Release. 2005;110(1):34\u201348. https:\/\/doi.org\/10.1016\/j.jconrel.2005.09.007.","journal-title":"J Control Release."},{"issue":"6","key":"2705_CR52","doi-asserted-by":"publisher","first-page":"228","DOI":"10.1208\/s12249-019-1438-4","volume":"20","author":"T Wang","year":"2019","unstructured":"Wang T, Zhang C, Zhong W, Yang X, Wang A, Liang R. Modification of three-phase drug release mode of octreotide PLGA microspheres by microsphere-gel composite system. Aaps Pharmscitech. 2019;20(6):228. https:\/\/doi.org\/10.1208\/s12249-019-1438-4.","journal-title":"Aaps Pharmscitech."}],"container-title":["AAPS PharmSciTech"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1208\/s12249-023-02705-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1208\/s12249-023-02705-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1208\/s12249-023-02705-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,12,30]],"date-time":"2023-12-30T07:03:24Z","timestamp":1703919804000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1208\/s12249-023-02705-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,11,30]]},"references-count":52,"journal-issue":{"issue":"8","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["2705"],"URL":"https:\/\/doi.org\/10.1208\/s12249-023-02705-6","relation":{},"ISSN":["1530-9932"],"issn-type":[{"value":"1530-9932","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,11,30]]},"assertion":[{"value":"3 September 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 November 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 November 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing Interests"}}],"article-number":"251"}}